Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
0.7%
1w
3.1%
1m
5.1%
3m
21.6%
6m
3.9%
1y
13.6%
all
2.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 174 0.7%
141
196
Company Overview

Sales
8,869 Cr
Growth: 0.2%
Profit after Tax
-347 Cr
Growth: 88.0%
Mid Cap
23,139 Cr
P/S: 2.6x
Industry P/S: 2.7x
Fundamentals

Sales (Cr) ₹ 8,869
Growth 0.2%
EBITDA 10.4%
P/S 2.6x
Dividend 0.1%
P/E -70.8x
Book Value ₹ 61.3
PEG Ratio -465.0x
ROE -4.3%
P/B 2.9x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Investors (6)
Followers (2)